13F-HR filed by ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-14, with 30 holding rows worth $281,229,000.
- Accession
- 0001493152-19-012469
- Filer
- CIK 1582844
- Filed
- 2019-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2019
A holdings report, 30 entries on the cover page, a total value of $281,229,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $281,229,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 2,426,701 | $59,503,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 200,000 | $17,542,000 | thousands by filing date | put |
| KADMON HLDGS INC | 48283N106 | COM | 7,617,500 | $15,692,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 1,190,000 | $14,149,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 481,500 | $13,728,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 478,500 | $12,680,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 551,000 | $12,116,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 81,000 | $11,468,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 437,500 | $11,266,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 255,000 | $11,166,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 435,500 | $11,149,000 | thousands by filing date | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 347,000 | $9,421,000 | thousands by filing date | |
| ATHENEX INC | 04685N103 | COM | 472,500 | $9,356,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 671,500 | $8,132,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 842,500 | $7,422,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 701,500 | $6,917,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 62,500 | $6,438,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 935,000 | $6,152,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 384,500 | $6,056,000 | thousands by filing date | |
| IRIDEX CORP | 462684101 | COM | 1,171,300 | $5,329,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 213,000 | $4,718,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 350,000 | $4,368,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 79,000 | $3,721,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 225,000 | $3,121,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 50,000 | $2,190,000 | thousands by filing date | put |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 50,000 | $2,190,000 | thousands by filing date | call |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 158,000 | $2,131,000 | thousands by filing date | |
| Danaher Corporation | 235851102 | COM | 11,500 | $1,644,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 280,000 | $1,210,000 | thousands by filing date | |
| CHEMBIO DIAGNOSTICS | 163572209 | COM | 41,667 | $254,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-19-012469 | this filing | 2019-08-14 | acceptance time not in the bulk data set |